1,25‐Dihydroxyvitamin D3 Exerts Opposing Effects to IL‐4 on MHC Class‐II Antigen Expression, Accessory Activity, and Phagocytosis of Human Monocytes

Scandinavian Journal of Immunology

Volumn 38, Issue 6, 1993, Pages 535-540

  XU, H ^a   SORURI, A ^a   GIESELER, R K H ^a   PETERS, J H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; INDOMETACIN; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ARTICLE; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PHAGOCYTOSIS;

ANTIGEN-PRESENTING CELLS; CALCITRIOL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMAN; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MACROPHAGES; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTES; PHAGOCYTOSIS; SUPPORT, NON-U.S. GOV'T; UP-REGULATION;

EID: 0027332649     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.1993.tb03237.x     Document Type: Article

References (31)

1. Vitamin D and the Immune system
2. 1.25‐Dihydroxyvitamin D3 and the immune system
3. 1,25‐dihydroxyvilamin D3 down‐regulation of HLA‐DR on human peripheral blood monocytes
4. Fraher Vitamin D3, gamma interferon, and control of proliferation of mycobacterium tuberculosis by human monocytes
5. 1,25‐dihydroxyvitamin D3 activates secretion of hydrogen peroxide by human monocytes
6. 1L‐4 decreases the expression of the monocyte differentiation marker CD14. paralleled by an increasing accessory potency
7. IL‐4 decreases Fc gamma R membrane expression and Fc gamma R‐mediated cytotoxic activity of human monocytes
8. IL‐4 inhibits superoxide production by human mononuclear phagocytes
9. Piccoli DS. Hamilton JA. Potential antiinflammatory effects of interleukin 4: Suppression of human monocyte tumor necrosis factor alpha, interleukin 1. and prostaglandin E2
10. Veiled accessory cells deduced from monocytes
11. Accessory phenotype and function ofmacrophages induced by cyclic adenosine monophosphate
12. Differentiation of human monocytes into CD14 negative accessory cells: Do dendritic cells derive from the monocytic lineage
13. Differentiation of human monocytes into accessory cells at serum‐free conditions
14. Adenosine and its derivatives control human monocyte differentiation into highly accessory cells versus macrophages
15. All CD2‐positive lymphocytes rosette with sheep erythrocytes in the presence of polyethylene glycol
16. Human dendritic cells exhibit a distinct T‐cell‐stimuIating mechanism and differentiation pattern
17. Functional and ultrastructural evidence for intracellular formation of major histocompatibility complex class II peptide complexes during antigen processing
18. IL‐4 and granulocyte‐macrophage colony‐stimulating factor selectively increase HLA‐DR and HLA‐DP antigens but not HLA‐DQ antigens on human monocytes
19. IL‐1: an immunological perspective
20. The biology of IL‐6
21. Interleukin‐4(IL‐4) inhibits secretion of 1L‐1 beta, tumor necrosis factor alpha, and IL‐6 by human monocytes
22. Differential effects of 1,25‐dihydroxyvitamin D3 on human lymphocytes and monocytes/ macrophages: inhibition of interleukin‐2 and augmentation of interleukin I production
23. The effects of 1,25‐dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: A cell cycle analysis
24. Accessory cell signals involved in T‐cell activation
25. Decreased accessory cell function and costimulatory activity by 1,25‐dihydroxy vitamin D3 treated monocytes
26. 1,25‐dihydroxyvitamin D3 enhances prostaglandin E2 production by monocytes. A mechanism which partially accounts for the antiproliferative effect of 1,25‐(OH)2‐D3 on lymphocytes
27. The HLA class II genes and products of the HLA‐D region
28. Quantitative variation in Ia antigen expression plays a central role in immune regulation
29. Antigen presentation: comments on its regulation and mechanism
30. r‐Interferon stimulates production of 1,25‐dihydroxyvitamin D3 by normal human macrophages. Biochcm
31. Production of 1.25‐dihydroxyvitamin D3 by human T cell lymphotropic virus‐transformed lymphocytes